Candriam Equities L Biotech.V2 USD Acc/ LU2026682919 /
| NAV13/05/2024 | Var.+13.0499 | Type of yield | Focus sugli investimenti | Società d'investimento |
|---|---|---|---|---|
| 1,809.4800USD | +0.73% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensile
| gen | feb | mar | apr | mag | giu | lug | ago | set | ott | nov | dic | Totale | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | - | - | - | - | - | - | - | - | 0.79 | -2.58 | 9.54 | 3.06 | - |
| 2021 | 1.89 | -2.53 | -4.20 | 2.79 | -2.19 | 6.44 | -1.39 | 3.98 | -4.17 | 0.23 | -4.31 | 2.49 | -1.66% |
| 2022 | -10.51 | -1.49 | 6.13 | -7.16 | -3.90 | 3.59 | 4.79 | 1.62 | -1.83 | 6.58 | 6.26 | -2.79 | -0.47% |
| 2023 | 3.00 | -5.59 | 0.33 | 2.35 | -0.85 | 1.51 | -0.49 | -0.14 | -4.41 | -6.03 | 6.25 | 13.72 | +8.38% |
| 2024 | 1.58 | 1.43 | 0.05 | -6.16 | 3.67 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 mesi | 1 anno | 3 anni | 5 anni | |
|---|---|---|---|---|---|
| Volatilità | 15.99% | 17.31% | 16.28% | 20.09% | -% |
| Indice di Sharpe | -0.19 | 2.36 | 0.09 | 0.01 | - |
| Mese migliore | +13.72% | +13.72% | +13.72% | +13.72% | - |
| Mese peggiore | -6.16% | -6.16% | -6.16% | -10.51% | - |
| Perdita massima | -10.91% | -10.91% | -15.44% | -28.30% | - |
| Outperformance | - | - | - | - | - |
Tutte le quotazioni in USD
Tranches
| Nome | Type of yield | Prezzo di riacquisto | 1 anno | 3 anni | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,022.5400 | +5.01% | +9.69% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 216.5200 | +4.70% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,027.4399 | +2.77% | +2.08% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,183.8799 | +5.54% | +22.83% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,379.4600 | +4.51% | +21.37% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 354.4400 | +4.63% | +25.16% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 319.4000 | +5.67% | +25.33% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 197.5100 | +0.43% | +0.45% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,809.4800 | +5.33% | +12.43% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 146.7200 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 588.5300 | +3.78% | +7.52% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,534.3799 | +4.91% | +9.30% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 193.8100 | +1.99% | +1.59% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 202.0700 | +2.87% | +4.10% | |
| Candriam Equities L Biotech.R US... | reinvestment | 262.2900 | +5.07% | +11.59% | |
| Candriam Equities L Biotechnolo... | reinvestment | 826.0500 | +4.16% | +8.88% | |
| Candriam Equities L Biotechnolog... | paying dividend | 754.4300 | +4.13% | +8.78% |
Prestazione
| YTD | +0.27% | ||
|---|---|---|---|
| 6 mesi | +20.08% | ||
| 1 anno | +5.33% | ||
| 3 anni | +12.43% | ||
| 5 anni | - | ||
| 10 anni | - | ||
| Dall'inizio | +20.63% | ||
| Anno | |||
| 2023 | +8.38% | ||
| 2022 | -0.47% | ||
| 2021 | -1.66% | ||
